Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TREK: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

NCT06001372 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT06001372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06001372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TREK: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Terminated
Start date
October 13, 2023
Completion date
March 12, 2024
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, gastrointestinal cancer